Propranolol treatment of infantile hemangiomas does not negatively affect psychomotor development

J Am Acad Dermatol. 2015 Aug;73(2):341-2. doi: 10.1016/j.jaad.2015.04.053.

Authors

Andre Vadimovich Moyakine¹, Denise Josephina Johanna Hermans², Joris Fuijkschot³, Catharina Joanna Maria van der Vleuten²

Affiliations

¹ Department of Dermatology, Hecovan Team for Hemangioma and Vascular Malformations, Radboud University Medical Centre, The Netherlands. Electronic address: [email protected].
² Department of Dermatology, Hecovan Team for Hemangioma and Vascular Malformations, Radboud University Medical Centre, The Netherlands.
³ Department of Pediatrics, Radboud University Medical Centre, The Netherlands.

PMID: 26183988
DOI: 10.1016/j.jaad.2015.04.053

No abstract available

Publication types

Letter

MeSH terms

Child, Preschool
Cohort Studies
Female
Hemangioma, Capillary / diagnosis
Hemangioma, Capillary / drug therapy*
Humans
Infant
Male
Neoplastic Syndromes, Hereditary / diagnosis
Neoplastic Syndromes, Hereditary / drug therapy*
Netherlands
Patient Safety
Propranolol / adverse effects
Propranolol / therapeutic use*
Psychomotor Performance / drug effects*
Retrospective Studies
Skin Neoplasms / diagnosis
Skin Neoplasms / drug therapy*
Tertiary Care Centers

Substances

Propranolol

Supplementary concepts

Hemangioma, capillary infantile